• Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients with Heart Failure with Reduced Ejection Fraction  

    Mikhail N Kosiborod, Marc S Sabatine, JAMA Cardiology

  • Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction with Statins, Ezetimibe, and PCSK9 Inhibition  

    Robert P Giugliano, Marc S Sabatine, JAMA Cardiology

  • PCSK9 Inhibition—A Tale of 2 Potential Treatment Opportunities—Reply  

    Brian A Bergmark, Marc S Sabatine, JAMA Cardiology
  • Join now to see all